Guj. Themis Bio.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE942C01045
  • NSEID: GUJTHEM
  • BSEID: 506879
INR
408.55
18.85 (4.84%)
BSENSE

Dec 19

BSE+NSE Vol: 8.71 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
RPG LifeScience.
Supriya Lifesci.
Guj. Themis Bio.
Sequent Scien.
Dishman Carbogen
Zota Health Care
Shilpa Medicare
Innova Captab
Orchid Pharma
Akums Drugs
SPARC
Why is Gujarat Themis Biosyn Ltd ?
1
High Management Efficiency with a high ROE of 32.79%
2
Company has a low Debt to Equity ratio (avg) at 0.05 times
3
Poor long term growth as Net Sales has grown by an annual rate of 9.27% and Operating profit at 5.21% over the last 5 years
4
Flat results in Sep 25
  • ROCE(HY) Lowest at 19.25%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 4.42 times
5
With ROCE of 19, it has a Very Expensive valuation with a 13.9 Enterprise value to Capital Employed
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 32.00%, its profits have fallen by -8.4%
6
Majority shareholders : Promoters
7
Market Beating performance in long term as well as near term
  • Along with generating 32.00% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Guj. Themis Bio. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Guj. Themis Bio. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Guj. Themis Bio.
32.0%
0.62
51.58%
Sensex
7.21%
0.61
11.73%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
9.27%
EBIT Growth (5y)
5.21%
EBIT to Interest (avg)
62.69
Debt to EBITDA (avg)
0.17
Net Debt to Equity (avg)
0.23
Sales to Capital Employed (avg)
0.96
Tax Ratio
24.98%
Dividend Payout Ratio
36.63%
Pledged Shares
3.30%
Institutional Holding
4.13%
ROCE (avg)
50.79%
ROE (avg)
32.79%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
92
Industry P/E
33
Price to Book Value
16.83
EV to EBIT
72.82
EV to EBITDA
64.70
EV to Capital Employed
13.85
EV to Sales
29.03
PEG Ratio
NA
Dividend Yield
0.16%
ROCE (Latest)
19.02%
ROE (Latest)
18.26%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
NET SALES(Q)

Highest at Rs 42.35 cr

PBDIT(Q)

Highest at Rs 20.95 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 49.47%

PBT LESS OI(Q)

Highest at Rs 17.94 cr.

PAT(Q)

Highest at Rs 14.26 cr.

EPS(Q)

Highest at Rs 1.31

-7What is not working for the Company
ROCE(HY)

Lowest at 19.25%

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.42 times

Loading Valuation Snapshot...
Here's what is working for Guj. Themis Bio.
Net Sales - Quarterly
Highest at Rs 42.35 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 20.95 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 49.47%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 17.94 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 17.94 cr has Grown at 24.5% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 14.41 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 14.26 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 14.26 cr has Grown at 27.9% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 11.15 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 1.31
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Guj. Themis Bio.
Debtors Turnover Ratio- Half Yearly
Lowest at 4.42 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio